Brief: Essa Pharma Reports Quarterly Net Loss Of $0.20/Shr

ESSA Pharma

04/08/2022 12:41

Aug 4 (Reuters) - ESSA Pharma Inc  EPIX.O :
    * ESSA PHARMA PROVIDES CORPORATE UPDATE AND REPORTS
FINANCIAL
RESULTS FOR FISCAL THIRD QUARTER ENDED JUNE 30, 2022
    * QTRLY NET LOSS OF $0.20 LOSS PER COMMON SHARE
    * COMPANY'S CASH POSITION IS EXPECTED TO BE SUFFICIENT TO
FUND
CURRENT AND PLANNED OPERATIONS THROUGH 2024
    * Q3 EARNINGS PER SHARE VIEW $-0.27 -- REFINITIV IBES DATA

Source text for Eikon:  ID:nCNWY95cba 
Further company coverage:  EPIX.O 

 ((Reuters.Briefs@thomsonreuters.com;))